Why the study?
Does morning administration of amlodipine 5 mg once daily improve blood pressure control and drug compliance compared to evening administration in outpatients with mild-to-moderate hypertension?
Does morning administration of amlodipine 5 mg once daily improve blood pressure control and drug compliance compared to evening administration in outpatients with mild-to-moderate hypertension?
The time of once-daily amlodipine administration does not inherently affect its 24-hour blood pressure lowering efficacy, but evening dosing may be associated with poorer medication compliance.
Answers are grounded in this paper and cite their sources.
Evening amlodipine maintains efficacy yet risks poorer adherence; supports flexible dosing with adherence monitoring and targeted trials.
OBJECTIVE: To test whether the time of administration influences the therapeutic response to a calcium antagonist taken once a day. Also, the dynamics of drug compliance and its impact on blood pressure control were investigated. DESIGN: Twenty outpatients with mild-to-moderate hypertension were included in a randomized, placebo-controlled open study. In a crossover design, all of the patients received 5 mg amlodipine, either in the morning or in the evening, during two consecutive 4-week treatment periods. METHODS: Blood pressure was taken by casual measurement, ambulatory 24-h monitoring (SpaceLabs 90202) and self-measurement at home, performed with a semi-automatic oscillometric device during the whole study period. Compliance was assessed using the Medication-Event-Monitoring System (MEMS). RESULTS: Neither casual nor ambulatory day- or night-time readings detected a significant difference between morning and evening administration. However, self-measurement documented significantly greater blood pressure reductions for morning than for evening administration. The MEMS showed different compliance on the days of ambulatory monitoring (100% with both drug regimens) compared with the whole treatment period. The number of days with missed medication was thus significantly higher for the evening dosing regimen. The difference in self-measured blood pressure between the two regimens was lost if the days with missed medication were removed from the statistical analysis. CONCLUSIONS: Time of once-a-day amlodipine administration does not influence its efficacy for 24-h blood pressure control. Furthermore, the use of self-measurement and the MEMS may provide useful additional information on the pharmacodynamic impact of different dosing patterns in hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Mengden et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: